Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking your way to better blood sugar: new study tests storytelling as diabetes tool

NCT ID NCT07307430

Symptom relief Sponsor: Mustafa Kemal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a structured storytelling education program can help adults with type 2 diabetes improve their blood sugar control. About 226 participants will either receive standard care or standard care plus two face-to-face storytelling sessions and four brief phone calls over three months. The main goal is to see if the program lowers HbA1c levels, a key measure of blood sugar control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Structured narrative education program (behavioral intervention)
What this could lead to
If it works, this could offer a simple, low-cost way to help people with type 2 diabetes better manage their blood sugar through improved self-care.
What could go wrong
This is a small, early-stage trial with only 226 participants. The program may not produce meaningful improvements in blood sugar, and results may not apply to all diabetes patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 226 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Diagnosis of type 2 diabetes mellitus for at least 1 year * HbA1c ≥ 7.0% measured within the last 3 months prior to enrollment * Followed in the study family health center and reachable by telephone * Able to read and write (or able to complete questionnaires with investigator assistance) * Provides written informed consent Exclusion Criteria: * Type 1 diabetes, gestational diabetes, or secondary diabetes * Acute infection or hospitalization within the last 2 weeks * Major surgery or blood transfusion within the last 3 months * Active malignancy or current systemic steroid/immunosuppressive therapy * Significant cognitive impairment preventing participation * Current participation in another structured diabetes education program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes education are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes education Diabetes self-management Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ozerli Family Health Center No. 4

    Antakya, Hatay, 31600, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.